Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunityRobert M Prins, Noah Craft, Kevin W Bruhn, et al.
Cells|January 11, 2024
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized MiceSebastian J Theobald, Elena Fiestas, Andreas Schneider, et al.
Experimental Hematology & Oncology|March 20, 2025
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasoneTheresa Kaeuferle, Maximilian Zwermann, Nadine Stoll, et al.
Toxicology and Applied Pharmacology|June 17, 2008
Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cellsTheodore Sarafian, Cindy Montes, Airi Harui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccinesRichard C Koya, Takahiro Kimura, Antoni Ribas, et al.
Frontiers in Immunology|February 23, 2023
GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignanciesXi Zhang, Tiaoxia Wang, Xiaona Zhu, et al.
Journal of Immunological Methods|June 1, 2014
Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approachesSabine Tischer, Daria Dieks, Cinja Sukdolak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotidesJoachim Köchling, Sven A König-Merediz, Renata Stripecke, et al.
Vaccine|November 26, 2009
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responsesAdan C Jirmo, Richard C Koya, Bala Sai Sundarasetty, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expressionTakahiro Kimura, Richard C Koya, Laura Anselmi, et al.
Pageof 6